Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

NCT02954263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults, Elderly Subjects

Interventions

DRUG: TD-1439
DRUG: Placebo

Sponsor

Theravance Biopharma